The graph in the SA article abput SUPN showing Vascepa's early sales as actually the best among seven recently marketed drugs (despite all the nay-saying by AF & company) brings to mind a couple of questions:
1) How long did Lovaza take from FDA approval to launch
2) How long after launching did it take Lovaza to get Tier II
"Vascepa's early sales as actually the best among seven recently marketed drug"
I think you're the first who noted it. Bravo.
Fact is that here the bash crew was expecting for megabillion$ sales in 6 weeks. Well, in that perspective, disappointing data of course.
Pay attention, pure speculation changes fast.